432 related articles for article (PubMed ID: 31678382)
21. Development of mechanistic models to identify critical formulation and process variables of pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Asfari S; Coburn J; Ghammraoui B; Aqueel S; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 555():109-123. PubMed ID: 30453019
[TBL] [Abstract][Full Text] [Related]
22. Extrudability analysis of drug loaded pastes for 3D printing of modified release tablets.
Zidan A; Alayoubi A; Coburn J; Asfari S; Ghammraoui B; Cruz CN; Ashraf M
Int J Pharm; 2019 Jan; 554():292-301. PubMed ID: 30439491
[TBL] [Abstract][Full Text] [Related]
23. 3D Printing of Medicines: Engineering Novel Oral Devices with Unique Design and Drug Release Characteristics.
Goyanes A; Wang J; Buanz A; Martínez-Pacheco R; Telford R; Gaisford S; Basit AW
Mol Pharm; 2015 Nov; 12(11):4077-84. PubMed ID: 26473653
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
25. Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation.
Abdelkader H; Youssef Abdalla O; Salem H
AAPS PharmSciTech; 2008; 9(2):675-83. PubMed ID: 18500558
[TBL] [Abstract][Full Text] [Related]
26. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
27. Fabrication of 3D-Printed Contact Lens Composed of Polyethylene Glycol Diacrylate for Controlled Release of Azithromycin.
Goto E; Tagami T; Ogawa K; Ozeki T
Biol Pharm Bull; 2023; 46(10):1461-1467. PubMed ID: 37779048
[TBL] [Abstract][Full Text] [Related]
28. An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing.
Gültekin HE; Tort S; Acartürk F
Pharm Res; 2019 Jun; 36(9):128. PubMed ID: 31250313
[TBL] [Abstract][Full Text] [Related]
29. 3D printed tablets with internal scaffold structure using ethyl cellulose to achieve sustained ibuprofen release.
Yang Y; Wang H; Li H; Ou Z; Yang G
Eur J Pharm Sci; 2018 Mar; 115():11-18. PubMed ID: 29305984
[TBL] [Abstract][Full Text] [Related]
30. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
31. Thermal Extrusion 3D Printing for the Fabrication of Puerarin Immediate-Release Tablets.
Li P; Jia H; Zhang S; Yang Y; Sun H; Wang H; Pan W; Yin F; Yang X
AAPS PharmSciTech; 2019 Dec; 21(1):20. PubMed ID: 31820224
[TBL] [Abstract][Full Text] [Related]
32. Pilot-scale binder jet 3D printing of sustained release solid dosage forms.
Tan M; Dharani D; Dong X; Maiorana C; Chaudhuri B; Nagapudi K; Chang SY; Ma AWK
Int J Pharm; 2023 Jan; 631():122540. PubMed ID: 36566828
[TBL] [Abstract][Full Text] [Related]
33. [Ginkgo biloba Ketone Ester Tablets with different release rates prepared by fused deposition modeling 3D printing technology].
Li YY; Chen C; Wang HX; Xiang BB; Li Z
Zhongguo Zhong Yao Za Zhi; 2022 Sep; 47(17):4643-4649. PubMed ID: 36164870
[TBL] [Abstract][Full Text] [Related]
34. 3D printing of drug-loaded gyroid lattices using selective laser sintering.
Fina F; Goyanes A; Madla CM; Awad A; Trenfield SJ; Kuek JM; Patel P; Gaisford S; Basit AW
Int J Pharm; 2018 Aug; 547(1-2):44-52. PubMed ID: 29787894
[TBL] [Abstract][Full Text] [Related]
35. 3D printing of tablets containing multiple drugs with defined release profiles.
Khaled SA; Burley JC; Alexander MR; Yang J; Roberts CJ
Int J Pharm; 2015 Oct; 494(2):643-650. PubMed ID: 26235921
[TBL] [Abstract][Full Text] [Related]
36. The effect of excipients on the release kinetics of diclofenac sodium and papaverine hydrochloride from composed tablets.
Kasperek R; Trebacz H; Zimmer Ł; Poleszak E
Acta Pol Pharm; 2014; 71(3):439-49. PubMed ID: 25265824
[TBL] [Abstract][Full Text] [Related]
37. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
38. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
Košir D; Ojsteršek T; Vrečer F
Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
[TBL] [Abstract][Full Text] [Related]
39. Oral preparations with tunable dissolution behavior based on selective laser sintering technique.
Yang Y; Xu Y; Wei S; Shan W
Int J Pharm; 2021 Jan; 593():120127. PubMed ID: 33253801
[TBL] [Abstract][Full Text] [Related]
40. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
